Prosperity Weaving Mills Limited (PSX:PRWM)

Ligand Pharmaceuticals Income Statement

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	18,947	18,746	14,655	12,861	8,151	6,019
Revenue Growth (YoY)	6.78%	27.91%	13.95%	57.79%	35.42%	-15.38%
Cost of Revenue	17,773	17,545	13,554	11,721	6,981	5,489
Gross Profit	1,174	1,201	1,101	1,139	1,169	529.56
Selling, General & Admin	540.89	565.16	512.12	348	254.7	199.4
Other Operating Expenses	41.82	35.96	36.89	90.19	60.24	19.24
Operating Expenses	582.71	601.12	549.01	438.19	314.94	218.63
Operating Income	591.54	599.66	551.7	701.2	854.51	310.92
Interest Expense	-264.42	-383.46	-218.65	-105.03	-75.97	-111.37
Interest & Investment Income	40.47	40.47	29.09	31.35	36.69	35.1
Currency Exchange Gain (Loss)	-5.85	-5.85	0.78	0.69	-0.02	-11.83
Other Non Operating Income (Expenses)	-25.35	-25.35	-20.24	-12.37	-13.07	-7.72
EBT Excluding Unusual Items	336.39	225.47	342.69	615.83	802.15	215.1
Gain (Loss) on Sale of Investments	0.59	0.59	0.2	5.09	4.21	24.39
Gain (Loss) on Sale of Assets	1.33	1.33	1.67	3.63	8.18	8.48
Pretax Income	338.3	227.39	344.56	624.55	814.54	247.97
Income Tax Expense	185.89	140.74	191.44	274.65	172.96	93.21
Net Income	152.41	86.65	153.13	349.9	641.58	154.76
Net Income to Common	152.41	86.65	153.13	349.9	641.58	154.76
Net Income Growth	134.62%	-43.41%	-56.24%	-45.46%	314.57%	-26.32%
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
EPS (Basic)	8.26	4.69	8.29	18.93	34.72	8.37
EPS (Diluted)	8.26	4.69	8.29	18.93	34.72	8.37
EPS Growth	135.01%	-43.41%	-56.24%	-45.46%	314.57%	-26.32%
Free Cash Flow	337.76	225.22	-404.39	-1,136	-114.54	628.94
Free Cash Flow Per Share	18.30	12.19	-21.88	-61.45	-6.20	34.03
Dividend Per Share	2.500	2.500	3.000	5.000	10.000	-
Dividend Growth	-16.67%	-16.67%	-40.00%	-50.00%	-	-
Gross Margin	6.20%	6.41%	7.51%	8.86%	14.35%	8.80%
Operating Margin	3.12%	3.20%	3.77%	5.45%	10.48%	5.17%
Profit Margin	0.80%	0.46%	1.04%	2.72%	7.87%	2.57%
Free Cash Flow Margin	1.78%	1.20%	-2.76%	-8.83%	-1.41%	10.45%
EBITDA	902.34	930.42	806.11	935.14	1,078	521.7
EBITDA Margin	4.76%	4.96%	5.50%	7.27%	13.22%	8.67%
D&A For EBITDA	310.8	330.76	254.41	233.94	223.3	210.78
EBIT	591.54	599.66	551.7	701.2	854.51	310.92
EBIT Margin	3.12%	3.20%	3.77%	5.45%	10.48%	5.17%
Effective Tax Rate	54.95%	61.89%	55.56%	43.97%	21.23%	37.59%
Advertising Expenses	-	0.17	0.33	0.1	0.09	0.16

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.